EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
PDF Report: Discover the rise of Digital Therapeutics (DTx) and the favourable market conditions driving its adoption for better patient outcomes.
In brief
With ageing populations, changes in lifestyle and heightened health awareness, there is a need for more comprehensive disease management to improve patient outcomes and address gaps in health care delivery
Mental health issues and burgeoning chronic conditions are becoming an increasing concern post-COVID-19 pandemic with shared unmet needs, and a need to provide a more comprehensive disease management solution to help both patients, physicians and alleviate burden on the healthcare system
Several companies are active in this space as the market continues to grow with significant regulatory changes and country level plans accelerating the use of Digital Therapeutics
A concerted collaborative effort across all key stakeholders in the healthcare ecosystem needs to be upheld effectively to ensure appropriate adoption
Pharmaceutical companies need to act now to take advantage of more favourable market conditions and reimbursement routes for digital therapeutics which may complement drug therapies and provide product differentiation
AI will have an important role in next-generation DTx solutions as care models move towards prevention
